These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 9835514

  • 1. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
    Berry V, Thorburn CE, Knott SJ, Woodnutt G.
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3193-9. PubMed ID: 9835514
    [Abstract] [Full Text] [Related]

  • 2. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
    Berry V, Hoover J, Singley C, Woodnutt G.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):908-15. PubMed ID: 15728883
    [Abstract] [Full Text] [Related]

  • 3. In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.
    Clark C, Bozdogan B, Peric M, Dewasse B, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2956-62. PubMed ID: 12183253
    [Abstract] [Full Text] [Related]

  • 4. Antibacterial effects of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae strains for which MICs are high, in an in vitro pharmacokinetic model.
    MacGowan AP, Noel AR, Rogers CA, Bowker KE.
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2599-603. PubMed ID: 15215115
    [Abstract] [Full Text] [Related]

  • 5. Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae.
    Woodnutt G, Berry V.
    Antimicrob Agents Chemother; 1999 Jan; 43(1):29-34. PubMed ID: 9869561
    [Abstract] [Full Text] [Related]

  • 6. Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
    Neuhauser MM, Prause JL, Danziger LH, Pendland SL.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3613-5. PubMed ID: 11709352
    [Abstract] [Full Text] [Related]

  • 7. Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children.
    Hoberman A, Dagan R, Leibovitz E, Rosenblut A, Johnson CE, Huff A, Bandekar R, Wynne B.
    Pediatr Infect Dis J; 2005 Jun; 24(6):525-32. PubMed ID: 15933563
    [Abstract] [Full Text] [Related]

  • 8. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
    McLinn S, Williams D.
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
    [Abstract] [Full Text] [Related]

  • 9. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004.
    Melo-Cristino J, Santos L, Ramirez M, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Rev Port Pneumol; 2006 Sep; 12(1):9-30. PubMed ID: 16572254
    [Abstract] [Full Text] [Related]

  • 10. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
    Thornsberry C, Ogilvie P, Kahn J, Mauriz Y.
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):249-57. PubMed ID: 9458982
    [Abstract] [Full Text] [Related]

  • 11. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.
    Torumkuney D, Mayanskiy N, Edelstein M, Sidorenko S, Kozhevin R, Morrissey I.
    J Antimicrob Chemother; 2018 Apr 01; 73(suppl_5):v14-v21. PubMed ID: 29659881
    [Abstract] [Full Text] [Related]

  • 12. Microbiologic activity of the newer macrolide antibiotics.
    McCracken GH.
    Pediatr Infect Dis J; 1997 Apr 01; 16(4):432-7. PubMed ID: 9109155
    [Abstract] [Full Text] [Related]

  • 13. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece.
    Torumkuney D, Papaparaskevas J, Morrissey I.
    J Antimicrob Chemother; 2018 Apr 01; 73(suppl_5):v36-v42. PubMed ID: 29659884
    [Abstract] [Full Text] [Related]

  • 14. Human serum activity of telithromycin, azithromycin and amoxicillin/clavulanate against common aerobic and anaerobic respiratory pathogens.
    Stein GE, Schooley S, Tyrrell KL, Citron DM, Goldstein EJ.
    Int J Antimicrob Agents; 2007 Jan 01; 29(1):39-43. PubMed ID: 17189093
    [Abstract] [Full Text] [Related]

  • 15. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M, Browne FA, Jacobs MR, Appelbaum PC.
    Clin Ther; 2003 Jan 01; 25(1):169-77. PubMed ID: 12637118
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
    Barry AL, Fuchs PC, Brown SD.
    Eur J Clin Microbiol Infect Dis; 1997 Oct 01; 16(10):767-9. PubMed ID: 9405952
    [Abstract] [Full Text] [Related]

  • 17. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM, Jacobs MR, Good CE, Bajaksouzian S, Windau A, Jakielaszek C, Saunders KA.
    Int J Infect Dis; 2004 Nov 01; 8(6):362-73. PubMed ID: 15494258
    [Abstract] [Full Text] [Related]

  • 18. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
    Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo MR.
    J Antimicrob Chemother; 2004 Aug 01; 54(2):542-5. PubMed ID: 15215227
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV, Brueggemann AB, Pierce G, Holley HP, Rauch A.
    Antimicrob Agents Chemother; 1997 Feb 01; 41(2):292-7. PubMed ID: 9021182
    [Abstract] [Full Text] [Related]

  • 20. Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin.
    Hoogkamp-Korstanje JA, Dirks-Go SI, Kabel P, Manson WL, Stobberingh EE, Vreede RW, Davies BI.
    J Antimicrob Chemother; 1997 Mar 01; 39(3):411-4. PubMed ID: 9096192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.